Question:
For CAR-T cell administration, can we report lymphodepleting (LD) chemotherapy separately if it is administered prior to the day that cell therapy is administered?
Answer:
Lymphodepleting (LD) chemotherapy administered prior to the day cell therapy is administered may be separately reported using the chemotherapy drug administration codes, unless, these infusions are done just prior to initiating cell therapy (same day) and in that scenario may not be separately reported.